MYNZ – mainz biomed b.v. (US:NASDAQ)

News

Mainz Biomed Announces 6.0 USD Million Private Placement and Strategic Update
Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting
Mainz Biomed Provides Review of 2025 Highlights [Yahoo! Finance]
Mainz Biomed Provides Review of 2025 Highlights
Mainz Biomed (NASDAQ:MYNZ) was upgraded by analysts at Wall Street Zen
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com